Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine
Abstract Background When patient health state transition evidence is missing from clinical literature, analysts are inclined to make simple assumptions to complete the transition matrices within a health economic model. Our aim was to provide a solution for estimating transition matrices by the Baye...
Main Authors: | Zoltán Vokó, István Bitter, Beatrix Mersich, János Réthelyi, Anett Molnár, János G. Pitter, Árpád Götze, Margit Horváth, Kristóf Kóczián, Laura Fonticoli, Filippo Lelli, Bertalan Németh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Cost Effectiveness and Resource Allocation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12962-020-00224-w |
Similar Items
-
Early-Onset Schizophrenia With Predominantly Negative Symptoms: A Case Study of a Drug-Naive Female Patient Treated With Cariprazine
by: Maria Judit Molnar, et al.
Published: (2020-04-01) -
Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
by: Balázs Szatmári, et al.
Published: (2020-03-01) -
Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats
by: László-István Bába, et al.
Published: (2020-10-01) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
by: Aubel T
Published: (2021-07-01) -
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
by: Henry A. Nasrallah, et al.
Published: (2017-08-01)